Clinical Trial Update: Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema

View source ↗

Summary

A completed clinical trial update examining changes in oxygen consumption after intravitreal ranibizumab (Lucentis) treatment for diabetic macular edema. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Kagawa University | Conditions: Diabetic Macular Edema | Status: COMPLETED